NO2885005T3 - - Google Patents

Info

Publication number
NO2885005T3
NO2885005T3 NO13747642A NO13747642A NO2885005T3 NO 2885005 T3 NO2885005 T3 NO 2885005T3 NO 13747642 A NO13747642 A NO 13747642A NO 13747642 A NO13747642 A NO 13747642A NO 2885005 T3 NO2885005 T3 NO 2885005T3
Authority
NO
Norway
Application number
NO13747642A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46832170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2885005(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2885005T3 publication Critical patent/NO2885005T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO13747642A 2012-08-20 2013-08-01 NO2885005T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12005960 2012-08-20
EP13747642.0A EP2885005B1 (en) 2012-08-20 2013-08-01 Solid pharmaceutical preparation containing levothyroxine
PCT/EP2013/002293 WO2014029464A1 (en) 2012-08-20 2013-08-01 Solid pharmaceutical preparation containing levothyroxine

Publications (1)

Publication Number Publication Date
NO2885005T3 true NO2885005T3 (es) 2018-02-24

Family

ID=46832170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13747642A NO2885005T3 (es) 2012-08-20 2013-08-01

Country Status (34)

Country Link
US (2) US20150231101A1 (es)
EP (1) EP2885005B1 (es)
JP (1) JP6195424B2 (es)
KR (1) KR102184254B1 (es)
CN (1) CN104582731B (es)
AR (1) AR092151A1 (es)
AU (1) AU2013304795B2 (es)
BR (1) BR112015003116B1 (es)
CA (1) CA2882372A1 (es)
CL (1) CL2015000390A1 (es)
CO (1) CO7200278A2 (es)
DK (1) DK2885005T3 (es)
EA (1) EA027189B1 (es)
EC (1) ECSP15010550A (es)
ES (1) ES2654306T3 (es)
HK (1) HK1204961A1 (es)
HR (1) HRP20171784T1 (es)
HU (1) HUE035222T2 (es)
IL (1) IL237322A0 (es)
LT (1) LT2885005T (es)
MX (1) MX353618B (es)
MY (1) MY184400A (es)
NO (1) NO2885005T3 (es)
NZ (1) NZ703038A (es)
PE (1) PE20150597A1 (es)
PH (1) PH12014502856A1 (es)
PL (1) PL2885005T3 (es)
PT (1) PT2885005T (es)
RS (1) RS56745B1 (es)
SG (1) SG11201501122WA (es)
SI (1) SI2885005T1 (es)
TW (1) TWI603730B (es)
UA (1) UA115247C2 (es)
WO (1) WO2014029464A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106267220B (zh) * 2015-05-14 2019-06-28 北京科信必成医药科技发展有限公司 愈创甘油醚氢溴酸右美沙芬无水吞服掩味制剂
EP3576795B1 (de) * 2017-02-03 2021-04-07 Berlin-Chemie AG Orales schilddrüsentherapeutikum
IT201800003615A1 (it) * 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli
EP3831373B1 (en) * 2018-07-30 2023-03-15 Daiichi Sankyo Company, Limited Stabilizer-containing solid drug formulation
CN109364043A (zh) * 2018-12-10 2019-02-22 唐熠达 一种治疗甲状腺功能异常的缓控释药物组合物
CN110075305A (zh) * 2019-05-22 2019-08-02 上海葆隆生物科技有限公司 一种含有左甲状腺素钠的药物组合物
CN115737576B (zh) * 2022-11-14 2024-05-07 山东创新药物研发有限公司 一种左甲状腺素钠片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401892D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
US6017958A (en) * 1996-06-04 2000-01-25 Octamer, Inc. Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
EP1025842B1 (en) * 1997-10-30 2004-07-21 Morishita Jintan Co., Ltd. Double-leyered capsule of unsaturated fatty acid or derivative thereof and process for producing the same
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
CA2523079C (en) * 2003-05-02 2012-08-14 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
US8293272B2 (en) 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
IT1395454B1 (it) * 2009-03-24 2012-09-21 Altergon Sa Composizioni e forme farmaceutiche per somministrazione orale di ormoni tiroidei in grado di contrastare l'azione di agenti sequestranti nel tratto gastrointestinale
US20110206775A1 (en) * 2010-01-27 2011-08-25 Groenewoud Pieter J Preparation of inert pharmaceutical excipients for stabilizing unstable pharmaceutical ingredients

Also Published As

Publication number Publication date
KR102184254B1 (ko) 2020-11-30
RS56745B1 (sr) 2018-03-30
CA2882372A1 (en) 2014-02-27
CN104582731A (zh) 2015-04-29
MY184400A (en) 2021-04-01
EA201500245A1 (ru) 2015-07-30
NZ703038A (en) 2018-01-26
SI2885005T1 (en) 2018-01-31
CN104582731B (zh) 2020-01-10
PH12014502856B1 (en) 2015-02-23
HRP20171784T1 (hr) 2017-12-29
US11298331B2 (en) 2022-04-12
DK2885005T3 (en) 2018-01-02
EP2885005B1 (en) 2017-09-27
EA027189B1 (ru) 2017-06-30
EP2885005A1 (en) 2015-06-24
PT2885005T (pt) 2018-01-03
BR112015003116B1 (pt) 2020-05-12
HK1204961A1 (en) 2015-12-11
ECSP15010550A (es) 2015-12-31
PH12014502856A1 (en) 2015-02-23
HUE035222T2 (hu) 2018-05-02
CL2015000390A1 (es) 2015-07-10
PE20150597A1 (es) 2015-05-06
PL2885005T3 (pl) 2018-01-31
BR112015003116A2 (pt) 2017-07-04
JP6195424B2 (ja) 2017-09-13
US20170304246A1 (en) 2017-10-26
MX2015001930A (es) 2015-06-22
MX353618B (es) 2018-01-22
TW201412305A (zh) 2014-04-01
AU2013304795B2 (en) 2017-11-23
CO7200278A2 (es) 2015-05-29
KR20150042289A (ko) 2015-04-20
ES2654306T3 (es) 2018-02-13
JP2015525802A (ja) 2015-09-07
UA115247C2 (uk) 2017-10-10
SG11201501122WA (en) 2015-03-30
AU2013304795A1 (en) 2015-04-02
TWI603730B (zh) 2017-11-01
IL237322A0 (en) 2015-04-30
US20150231101A1 (en) 2015-08-20
WO2014029464A1 (en) 2014-02-27
LT2885005T (lt) 2017-12-27
AR092151A1 (es) 2015-03-25

Similar Documents

Publication Publication Date Title
BR112014017635A2 (es)
BR112014017614A2 (es)
BR112014017625A2 (es)
BR112014017659A2 (es)
BR112014017646A2 (es)
BR112014019120A2 (es)
BR112014017638A2 (es)
BR112014017607A2 (es)
BR112014017634A2 (es)
BR112014018522A2 (es)
BR112014017609A2 (es)
BR112014017644A2 (es)
BR112014017647A2 (es)
BR112014017618A2 (es)
BR112014013184A8 (es)
BR112014017652A2 (es)
BR112014017621A2 (es)
BR112014017630A2 (es)
BR112014017622A2 (es)
BR112014017627A2 (es)
BR112014017623A2 (es)
BR112014017641A2 (es)
BR112014017631A2 (es)
BR112014018301A2 (es)
BR112014017636A2 (es)